Crinetics Pharmaceuticals Inc buy SVB Leerink LLC
Start price
29.09.25
/
50%
€38.40
Target price
29.09.26
€75.07
Performance (%)
11.98%
Price
12.12.25
€43.00
Summary
This prediction is currently active. The prediction currently has a performance of 11.98%. This prediction currently runs until 29.09.26. The prediction end date can be changed by SVB_Leerink_LLC at any time. SVB_Leerink_LLC has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Crinetics Pharmaceuticals Inc | 5.392% | 5.392% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by SVB_Leerink_LLC for this prediction
In the thread Crinetics Pharmaceuticals Inc diskutieren
Crinetics Pharmaceuticals (NASDAQ:CRNX) had its price target raised by analysts at Leerink Partners from $80.00 to $88.00. They now have an "outperform" rating on the stock.
Ratings data for CRNX provided by MarketBeat